Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013154512) PHARMACEUTICAL FORMULATIONS COMPRISING DEXIBUPROFEN
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/154512 International Application No.: PCT/TR2013/000111
Publication Date: 17.10.2013 International Filing Date: 03.04.2013
IPC:
A61K 9/20 (2006.01) ,A61K 31/192 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
192
having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Applicants:
BILGIC, Mahmut [TR/TR]; TR
Inventors:
BILGIC, Mahmut; TR
Agent:
SİMSEK, Merve.M.; Yildiz Teknik Univ. Davutpasa Kampusu Teknopark Alanı D Blok Esenler Istanbul, TR
Priority Data:
2012/0430213.04.2012TR
Title (EN) PHARMACEUTICAL FORMULATIONS COMPRISING DEXIBUPROFEN
(FR) FORMULATIONS PHARMACEUTIQUES CONTENANT DU DEXIBUPROFÈNE
Abstract:
(EN) The present invention relates to formulations comprising dexibuprofen used in symptomatic treatment for prophylaxis of pain and inflammation associated with osteoarthritis, in symptomatic treatment of primary dysmenorrhea, in symptomatic treatment of all mild to moderate musculoskeletal system or dental pains. Said formulations are characterized in being in tablet form.
(FR) La présente invention concerne des formulations contenant du dexibuprofène et qui sont utilisées dans le cadre du traitement symptomatique et prophylactique de la douleur et de l'inflammation associées à l'arthrose, dans le cadre du traitement symptomatique de la dysménorrhée primaire, dans le cadre du traitement symptomatique de toutes les douleurs légères à modérées touchant le système musculo-squelettique et les dents. Lesdites formulations se caractérisent en ce qu'elles se présentent sous la forme de comprimés.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)